Evaluating enzyme replacement therapies for Anderson-Fabry disease : commentary on a recent report
Visualizar/abrir
Data
2018Autor
Tipo
Assunto
Abstract
Anderson-Fabry disease (AFD) is a rare lysosomal storage disorder. Randomized controlled clinical trials (RCTs) are preferred as the highest category of evidence, but limited availability of robust evidence in rare diseases may necessitate the use of less rigorous evidence. An analysis of cohort studies of enzyme replacement therapies for AFD published in 2017 by El Dib and coworkers made treatment recommendations that contradict previously published findings from RCTs and a systematic Cochrane ...
Anderson-Fabry disease (AFD) is a rare lysosomal storage disorder. Randomized controlled clinical trials (RCTs) are preferred as the highest category of evidence, but limited availability of robust evidence in rare diseases may necessitate the use of less rigorous evidence. An analysis of cohort studies of enzyme replacement therapies for AFD published in 2017 by El Dib and coworkers made treatment recommendations that contradict previously published findings from RCTs and a systematic Cochrane review. Our commentary outlines concerns regarding selection criteria and statistical methods with their analysis. ...
Contido em
Genetics and molecular biology. Ribeirão Preto. vol. 41, no. 4 (Oct./Dec. 2018), p. 790-793.
Origem
Nacional
Coleções
-
Artigos de Periódicos (39349)Ciências da Saúde (10585)
-
Artigos de Periódicos (39349)Ciências Biológicas (3068)
Este item está licenciado na Creative Commons License
![](/themes/Mirage2Novo//images/lume/cc.png)